Creating technologies for the peptides and oligonucleotides field - STA Pharmaceutical
Yu Lu, VP Business Operations at STA Pharmaceutical, a WuXi AppTec company, explains how the company has established its technological platforms for the oligos and peptides market and where it sees the field developing in the future.
This interview was filmed as part of TIDES TV at TIDES US in San Diego, CA, May 20-23, 2019.
Join us at TIDES Europe, Amsterdam, 12-15 November 2019: https://bit.ly/2IoyYP2
Видео Creating technologies for the peptides and oligonucleotides field - STA Pharmaceutical канала Informa Connect Life Sciences
This interview was filmed as part of TIDES TV at TIDES US in San Diego, CA, May 20-23, 2019.
Join us at TIDES Europe, Amsterdam, 12-15 November 2019: https://bit.ly/2IoyYP2
Видео Creating technologies for the peptides and oligonucleotides field - STA Pharmaceutical канала Informa Connect Life Sciences
Показать
Комментарии отсутствуют
Информация о видео
7 июня 2019 г. 15:34:36
00:07:26
Другие видео канала
Finding safe targets in the CAR-TCR fieldBWB TV: Moving toward continuous biomanufacturing with Miriam Monge, SartoriusTIDES 2023: Advantages of Fujimat as Standalone Liquid Phase Synthesis ReagentDiversity and Inclusion in BiotechUsing Kaneka affinity resins in the development and manufacture of antibodiesJens Vogel, Boehringer Ingelheim, on an exciting time for biotech manufacturingBioprocess automation and Biopharm 4.0 with GE HealthcareTIDES 2014 Interview: Jared A. Gollob, M.D., Alnylam Pharmaceuticals, Inc.Highlights from ePharma 2017How technology can simplify medical device regulatory compliance | Veeva SystemsIBC USA Virtual Poster Series: Venkata Mangalampalli, NIAID, NIHHighlights from TIDES 2016Remaining patient-centric when treating rare diseases - PRA Health SciencesDr John McCafferty on how his antibody phage display work led to a Nobel PrizeBWB 2016 Interview: David DiGiusto, Stanford Health CareBiotech Week Boston 2017 PreviewAntibody Engineering: A Systems Approach to Studying Disease Enabled by Emerging TechnologiesOptimizing drug development digitally | Jeff Kim, EPAMRapid handheld microbe detection with smart nanomaterials - RAN BiotechnologiesHighlights from the Antibody Engineering & Therapeutics Event